In a short period of time, TransCelerate has achieved unprecedented progress, delivering tangible impact to benefit the broader biopharmaceutical industry. All this would not have been achievable without the active engagement and sponsorship from some of the most senior leaders in the industry.
In just a few years, our leaders have made significant strides toward our goal of making clinical development more efficient. TransCelerate leadership has an unwavering dedication to assessing, refining and creating processes to make the drug development environment efficient, safe and innovative.
Board of Directors
Senior Vice President, Global Development, Amgen
Executive Vice President and Chief R&D Officer, Allergan
Senior Vice President, Global Clinical Development, Merck Research Laboratories
Executive Vice President, Global Medicines Development, and Chief Medical Officer, AstraZeneca Pharmaceuticals
Senior Vice President, Worldwide Head of Development Operations, Pfizer
Senior Vice President, Corporate Division Medicine and Chief Medical Officer, Boehringer Ingelheim GmbH
Senior Vice President, Clinical Operations, Novo Nordisk A/S
Executive Vice President and Chief Medical Officer, UCB
Executive Vice President of Science and Technology, Eli Lilly & Co.
Executive Vice President, Chief Development Officer, Pfizer Inc.
Head of Global Clinical Operations (GCO), Bristol-Myers Squibb
Senior Vice President, Head of Global Clinical Development, EMD Serono, Inc.
Senior Vice President, Global Head of Pharma Regulatory and Policy, Roche
SVP and Head of Projects, Clinical Platforms and Sciences (PCPS), GSK
Senior Executive Officer, Executive General Manager, Global Development, Shionogi & Co., Ltd.
Chief Medical Officer, AbbVie
Head, Global Development Operations, Novartis
Chief Scientific Officer, Worldwide Chairman of Pharmaceuticals, Johnson & Johnson
President of Global R&D, Sanofi
President, Global Development, Astellas Pharma